Batoosingh; Amy L.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Batoosingh; Amy L..The latest application filed is for "combination of brimonidine and timolol for topical ophthalmic use".

Company Profile

1.12.17

Batoosingh; Amy L. - Mission Viejo CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Combination Of Brimonidine And Timolol For Topical Ophthalmic Use App 20210405280 - Chang; Chin-Ming ; et al.	2021-12-30
Combination Of Brimonidine And Timolol For Topical Ophthalmic Use App 20200129520 - Chang; Chin-Ming ; et al.	2020-04-30
Combination Of Brimonidine And Timolol For Topical Ophthalmic Use App 20180064720 - Chang; Chin-Ming ; et al.	2018-03-08
Combination Of Brimonidine And Timolol For Topical Ophthalmic Use App 20180064721 - Chang; Chin-Ming ; et al.	2018-03-08
Combination of brimonidine and timolol for topical ophthalmic use Grant 9,907,802 - Chang , et al. March 6, 2	2018-03-06
Combination of brimonidine and timolol for topical ophthalmic use Grant 9,907,801 - Chang , et al. March 6, 2	2018-03-06
Combination Of Brimonidine And Timolol For Topical Ophthalmic Use App 20180042932 - Chang; Chin-Ming ; et al.	2018-02-15
Combination of brimonidine and timolol for topical ophthalmic use Grant 9,770,453 - Chang , et al. September 26, 2	2017-09-26
Combination Of Brimonidine And Timolol For Topical Ophthalmic Use App 20170157138 - Chang; Chin-Ming ; et al.	2017-06-08
Combination of brimonidine and timolol for topical ophthalmic use Grant 9,474,751 - Chang , et al. October 25, 2	2016-10-25
Combination Of Brimonidine And Timolol For Topical Ophthalmic Use App 20160303119 - Chang; Chin-Ming ; et al.	2016-10-20
Combination Of Brimonidine And Timolol For Topical Ophthalmic Use App 20150087647 - Chang; Chin-Ming ; et al.	2015-03-26
Combination of brimonidine and timolol for topical ophthalmic use Grant 8,748,425 - Chang , et al. June 10, 2	2014-06-10
Combination Of Brimonidine And Timolol For Topical Ophthalmic Use App 20130324534 - Chang; Chin-Ming ; et al.	2013-12-05
Combination Of Brimonidine And Timolol For Topical Ophthalmic Use App 20130196995 - Chang; Chin-Ming ; et al.	2013-08-01
Combination Of Brimonidine And Timolol For Topical Ophthalmic Use App 20130116255 - Chang; Chin-Ming ; et al.	2013-05-09
Combination of brimonidine and timolol for topical ophthalmic use Grant 8,354,409 - Chang , et al. January 15, 2	2013-01-15
Combination Of Brimonidine And Timolol For Topical Ophthalmic Use App 20120184551 - Chang; Chin-Ming ; et al.	2012-07-19
Combination of brimonidine and timolol for topical ophthalmic use Grant 8,133,890 - Chang , et al. March 13, 2	2012-03-13
Combination of brimonidine and timolol for topical ophthalmic use Grant 7,642,258 - Chang , et al. January 5, 2	2010-01-05
Combination of Brimonidine and Timolol for Topical Ophthalmic Use App 20080132512 - Chang; Chin-Ming ; et al.	2008-06-05
Combination Of Brimonidine And Timolol For Topical Ophthalmic Use App 20080103153 - Chang; Chin-Ming ; et al.	2008-05-01
Combination of brimonidine and timolol for topical ophthalmic use Grant 7,323,463 - Chang , et al. January 29, 2	2008-01-29
Combination of brimonidine and timolol for topical ophthalmic use Grant 7,320,976 - Chang , et al. January 22, 2	2008-01-22
Combination of brimonidine timolol for topical ophthalmic use Grant 7,030,149 - Chang , et al. April 18, 2	2006-04-18
Combination of brimonidine and timolol for topical ophthalmic use App 20040102445 - Chang, Chin-Ming ; et al.	2004-05-27
Combination of brimonidine and timolol for topical ophthalmic use App 20030199507 - Chang, Chin-Ming ; et al.	2003-10-23
Combination of brimonidine and timolol for topical ophthalmic use App 20030199509 - Chang, Chin-Ming ; et al.	2003-10-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.